Stocks analysis

Analysis for SPCX

  • 📈 Growth — 25/30
  • 💰 Profitability — 14/20
  • 🏦 Financial Health — 16/20
  • 💵 Valuation — 10/20
  • ⚠️ Risk — 8/10
Overall Score: 67/100

Summary:


📈 Growth & Financial Trajectory

Over the two quarters, Revenues grew from about $4.69B in Q1 2026 to $7.81B in Q2 2026, a robust ~66% step up. Net income loss narrowed dramatically from about -$4.92B to -$0.54B, with basic earnings per share moving from -$1.03 to -$0.09. While this period shows material top-line acceleration and improving profitability signals, the company remains loss-making.

The dataset covers two quarters; the trend hints at momentum as gross profit expands (Q1: $2.31B; Q2: $4.32B) and operating losses shrink (Q1: -$1.94B; Q2: -$0.14B). If this trajectory continues, margins could improve further, but profitability remains negative.

💰 Margins & Cash Flow

  • Gross Margin: ~49% in Q1 to ~55% in Q2, driven by higher gross profit relative to revenue (Q1 $2.31B; Q2 $4.32B).
  • Operating Loss narrowed from about -$1.94B to -$0.14B; operating leverage appears improving, while R&D (~$3.55B per quarter) and SG&A remain substantial.
  • Cash flow specifics are not provided in the data; thus, operating/investing cash flow trends cannot be assessed.

🛡️ Balance Sheet & Liquidity

  • Total Assets: $192.77B; Equity $127.224B; Long-term Debt $38.285B.
  • Current Assets $108.047B vs Current Liabilities $21.122B; coverage appears strong, and the equity cushion supports resilience given a moderate leverage profile.

⚠️ Key Drivers & Risks

  • Drivers: AI-enabled data/intelligence and ongoing space program funding; large-scale R&D investment.
  • Risks: Continued negative earnings despite revenue growth; sensitivity to defense/space budget cycles and execution risk.